Skin and soft tissue infections (SSTI) (IDSA 2014)

From IDWiki

Introduction

  • Exposure history is important
  • Physical examination for diagnosis
  • History must include
    • Immune status
    • Geographic locales
    • Travel history
    • Recent trauma and surgeries
    • Recent antibiotics exposure
    • Lifestyle
    • Hobbies
    • Animal exposures

Impetigo and Ecthyma

Background

  • Impetigo is a superficial infection of the epidermis (?)
  • Bullous impetigo is caused by Staph. aureus strains that produce a toxin that cleaves the dermal-epidermal junction
  • Non-bullous impetigo can be caused by Staph. aureus and Group A Strep
  • Ecthyma is a deeper infection, and heals with scarring

Organisms

Management

  • Gram stain and culture of any pus, if possible
  • Superficial and localized infections can be treated with topical mupirocin BID x5d
  • Otherwise, treat with dicloxacillin or cephalexin x7d
  • Can narrow if cultures grow Group A Strep alone
  • If MRSA, treat with doxycycline, clindamycin, or Septra

Purulent SSTIs

  • Includes abscesses, furuncles, carbuncles, and inflamed epidermoid cysts

Abscesses and inflamed epidermoid cysts

  • Epidermoid cysts contain skin flora in keratinous material and are not necessarily infected, but can become inflamed if the capsule ruptures
  • Organisms: Staph. aureus and skin flora
  • Management
    • Incision and drainage; no packing (increases pain without changing outcomes)
    • Add antibiotics if impaired immunity or systemic symptoms

Furuncles and carbuncles

  • Furuncles are small abscesses of hair follicles
  • Carbuncles involve many adjacent follicles
  • Organisms: almost exclusively Staph. aureus
  • Management
    • Often drain spontaneously with warm wet compresses
    • If large enough, can incise and drain
    • No need for antibiotics unless systemic symptoms

Recurrent abscesses (at the same site)

  • Differential diagnosis includes foreign body, hidradenitis suppuritiva, and pilonidal cysts
  • Organisms: excluding above causes, often Staph. aureus
  • Management
    • Treat underlying cause, if possible
    • Can try MRSA decolonization with
      • Intranasal mupirocin BID for 5 days each month, with daily chlorhexadine washes
      • Clindamycin 150mg for 3 months
  • If present since childhood, rule out a neutrophil disorder

Erysipelas and Cellulitis

Background

  • Infections of the dermis and subcutaneous fat, characterized by diffuse areas of erythema, edema, and tenderness
  • Specifically *not *purulent; if there's an abscess, then it's an abscess with surrounding erythema (not with surrounding cellulitis)
  • Erysipelas refers to either (1) a superficial infection of the upper dermis, or (2) a cellulitis of the face, or (3) a synonym of cellulitis
  • On examination, there can also be lymphangitis, peau d'orange, vesicles, bullae, or hemorrhagic lesions
  • Occasionally, the fever can precede the skin findings
  • Risk factors include: obesity, trauma, surgery, prior cellulitis, venous insufficiency, lymphedema

Organisms

  • Group A Strep
  • Other streptococci
  • Staph. aureus

Management

  • Blood cultures are unnecessary unless there is something unusual, immunosuppression, or sepsis
  • Treat with an antistreptococcal antibiotic, such as penicillin, amoxicillin, dicloxacillin, cephalexin, or clindamycin for 5 days
  • No need to empirically cover MRSA
  • Treat any underlying skin breach, including macerated skin between the toes
  • Can use prednisone (if no diabetes) or NSAIDs to help symptoms resolve faster

Recurrent infections

  • Identify and treat predisponsing conditions: edema, obesity, eczema, venous insufficiency, and toe web abnormalities
  • Prophylactic antibiotics can be considered in patients who have 3-4 episodes per year despite treating their predisposing factors
    • Oral penicillin or sythromycin bid for 4 to 52 weeks
    • IM benzathine penicillin every 2-4 weeks
  • Continue prophylaxis until the predisposing factors resolve

Surgical site infections

Background

  • Three classes
    • Superficial incisional SSI: involve only the subcutaneous space, occurs within 30 days, and has one of:
      • Purulent drainage
      • Positive culture of aseptically-obtained fluid or tissue
      • Local cellulitis after the wound has been opened
      • Expert opinion suggests SSI
    • Deep incisional SSI: involves fascia and mucle, within 30 days (or 1 year if prosthesis inserted), and same as above
    • Organ/space SSI: same as deep SSI but may involve organs and deep space, e.g. peritonitis, empyema, and joint infections

Organisms

  • Depends in part on site of incision, but generally S. aureus and streptococcal species
  • Axillary incisions may have more gram-negative organisms, and paerineal incisions have more gram-negatives and anaerobes

Management

  • Open the incision and evacuate the cavity
  • Drainage alone if <5cm erythema and minimal systemic symptoms
  • For some reason, IDSA seems to suggests tazo or mero as first-line; possibly just for gastrointestinal and genitourinary incisions

Necrotizing Fasciitis

Background

  • Involve the fascial or muscle compartments and are life-threatening
  • Usually develop from initial skin trauma, which can be trivial including insect bites
  • Presents as a rapidly-progressing cellulitis, with systemic symptoms and pain out of proportion to findings
  • May have wooden-hard induration, and if there is an open wound, you can easily dissect the fascial planes
  • Risk factors include diabetes

Organisms

Management

  • CT or MRI is not diagnostic
  • Surgical exploration for diagnosis and deep tissue cultures
  • Surgical intervention urgently, and daily until source control is achieved
  • Treat with antibiotics until source control achieved and afebrile for 48-72 hours
  • Empiric antibiotics should cover gram-positives, gram-negatives, and anaerobes
  • Group A streptococcal toxic shock syndrome should be treated with clindamycin and penicillin
    • The utility of IVIg is unclear; small RCT suggests not

Fournier gangrene

  • Variant involving the scrotum and penis or vulva, where a perianal or retroperitoneal infection has spread to the genitalia
  • Testes, glans, and spermatic cord are typically spared
  • Mostly mixed aerobes and anaerobes

Pyomyositis

Background

  • Pus within an individual muscle group, often associated with tropical climates
  • Risk factors include tropical climates, HIV, diabetes
  • May have a firm woody feel
  • CK often normal

Organisms

  • Staph. aureus in 90%
  • Group A Strep and gram-negative enterics also possible

Investigations

  • MRI establishes the diagnosis, though CT and US are useful
  • Get blood cultures (positive in 5-30%)
  • Repeat imaging if persistently bacteremic in order to find other infections

Management

  • Needs incision and drainage
  • Vancomycin is appropriate empiric therapy
  • Add Gram-negative coverage if immunocompromised or open trauma
  • Cefazolin for oxacillin for MSSA
  • Duration is with IV until better and not bacteremic, then oral to complete 2-3 weeks

Gas Gangrene and Myonecrosis

Background

  • Increasing pain at the injury site within 24 hours
  • Skin starts pale, then bronze, then purplish-red, tenderness at the site, followed by reddish-blue bullae
  • Septic

Organisms

  • Clostridium perfringens, C. novyi, C. histolyticum, and C. septicum
  • C. perfringens most commonly associated with trauma-associated gangrene, and C. septicum with spontaneous gangrene in neutropenic patients or those with GI malignancy

Management

  • Many organisms produce gas, so needs broad empiric coverage with pip/tazo, amp/sulb, or carbapenem
  • Penicillin + clindamycin is the recommended treatment
  • Unclear role for hyperbaric oxygen

Animal Bites

Prophylaxis

  • Unclear benefit of prophylaxis, but suggest 3-5 days of amox/clav to cover aerobes and anaerobes in high-risk patients
    • Immunocompromised
    • Asplenic
    • Advanced liver disease
    • Preexisting edema in the affected area
    • Moderate to severe injuries, especially hand or face
    • Injuries that penetrate the periosteum or joint capsule
  • Should be assessed for rabies prophylaxis
  • Avoid primary wound closure except on the face, in which case it should be done with copious irrigation

Wound infections

  • Purulent wounds are often polymicrobial, and need to cover aerobes and anaerobes
  • Nonpurulent wounds are often monomicrobial with staphylococci and streptococci, but are also sometimes polymicrobial
  • Pasteurella is common in both
  • Antibiotic options
    • Amox/clav is good empiric coverage
    • 2nd and 3rd gen cephalosporins +/- clinda/metronidazole
    • Carbapenems
    • Moxifloxacin
    • Doxycycline
    • Septra + clinda/metronidazole
    • Levfloxacin + clinda/metronidazole
  • Human bites also include streptococci, S. aureus, Eikonella corrodens, Fusobacterium, Peptostreptococcus, Prevotella, and Porphyromonas
    • Eikonella is resistant to 1st-gen cephalosporins but amox/clav is good as is moxifloxacin

Tetanus toxoid

  • Give tetanus toxoid vaccine if not vaccinated within 10 years
  • Tdap preferred to Td, if they haven't previously received it

Cutaneous Anthrax

Background

  • Incubation period 1-12 days followed by pruritis, then papule, then vesicles, the finally painless ulcer with black eschar without pus
  • Eschar sloughs after 12-14 days
  • Surrounding edema can be minimal or severe and lymphadenopathy is common
  • Often mild systemic symptoms
  • Diagnosis
    • Vesicles: unroof and soak 2 dry swabs in the vesicular fluid
    • Ulcer: 2 moist swabs in the ulcer base or along the eschar edge
    • Punch biopsy for immunohistochemistry or PCR

Management

  • Oral penicillin V 500 mg qid x7-10 days
  • If bioterrorism/aerosol exposure, ciprofloxacin 500 mg po bid or levofloxacin 500 mg poVI daily for 60 days

Bacillary Angiomatosis and Cat Scratch Disease

Background

Cat scratch disease

  • Caused by Bartonella henselae
  • After an incubation period of 3-30 days following a scratch or bite, a papule or pustule forms
  • Lymphadenopathy develops at about 3 weeks, and resolveds within 1-6 months
  • Occasionally, nodes can drain; rarely, extranodal visceral disease can occur

Bacillary angiomatosis

  • Caused by Bartonella henselae or B. quintana in immunocompromised patients, especially those with AIDS
  • Can appear either as red papular that vary in size (millimeter to centimeters) and number (1 to 1000), or as subcutaneous, painful nodules with overlying normal or dusky skin

Diagnosis

  • Fastidious, difficult-to-grow
  • Serology cross-reacts between B. henselae and B. quintana
  • PCR is one option

Management

Cat scratch disease

  • If >45 kg: azithromycin 500 mg on day 1 then 250 mg daily for 4 more days
  • If <45 kg: azithromycin 10 mg/kg on day 1 then 5 mg/kg daily for 4 more days

Bacillary angiomatosis

  • Erythromycin 500 mg qid or doxycycline 100 mg bid for 2 weeks to 2 months

Erysipeloid

Background

  • Cutaneous infection caused by Erysipelothrix rhusiopathiae, a thin, pleomorphic, non-spore-forming Gram-positive rod
  • Acquired by handling fish, marine animals, swine, or poulty
  • Incubation period of 1 to 7 days, followed by red maculopapular lesion on fingers or hands, spreading centrifugally with central clearing
  • May have a blue ring with peripheral red halo (target appearance)
  • Lymphadenopathy is common, though systemic symptoms are not
  • Diagnosed by aspirate and culture

Management

  • Penicillin 500 mg qid or amoxicillin 500 mg tid for 7 to 10 days
  • ALternatives include cephalosporins, clindamycin, and fluoroquinolones
  • Resistant to vancomycin, teicoplanin, and daptomycin

Glanders

  • Caused by Burkholderia mallei, an aerobic Gram-negative rod
  • Acquired from horses and mules through skin contact or inhalation
  • Causes ulcerating nodular lesions of the skin and mucosa
  • Treated with ceftazidime, gentamicin, imipenem, doxycycline, or ciprofloxacin for a prolonged course (?6 months)

Bubonic Plague

  • Caused by Yersinia pestis, a facultative anaerobic Gram-negative coccobacillus
  • Acquired from rodents
  • Three syndromes:
    • Bubonic
      • Most common and classic, acquired from infected fleas or through breached skin
      • Incubation period of 2 to 6 days followed by fever, headache, chills, and regional lymphadenopathy
      • Skin lesion sometimes present at site of entry
      • May progress to septicemia and secondary pneumonia
    • Septicemic
    • Pneumonic
      • Transmissible human-to-human
  • Diagnosis made by blood culture, lymph node aspirate, or PCR; serology may be helpful for confirming the diagnosis retrospectively
  • Treatment
    • Streptomycin 15 mg/kg bid for 10 to 14 days
    • Alternatives: genatmicin, tetracycline, chloramphenicol, maybe fluoroquinolones
    • If pneumonic form develops, needs to be in droplet isolation until 48 hours of effective therapy

Tularemia

  • Gram-negative coccobacillus Francisella tularensis
  • Distinct syndromes:
    • Ulceroglandular
    • Glandular
    • Typhoidal
    • Pneumonic
    • Oculoglandular
    • Oropharyngeal
  • Acquired by handling infected animals, by tick bites, sometimes by animal bites (especially cats), as well as by biting flies or mosquitoes
  • Skin ulcer forms at site of bite after 3-10 days with tender adenopathy, fevers, headache, and malaise (ulceroglandular syndrome)
  • If the ulcer heals quickly, with ongoing symptoms, they may present without the ulcer as glandular syndrome
  • Diagnosis
    • Serology
    • Culture with cysteine-supplemented media; notify the lab first
    • PCR may be useful
  • Treatment
    • Streptomycin 15 mg/kg/day q12h (max 2 g per day)
    • Gentamicin 1.5 mg/kg q8h (or 2 mg/kg q8h in children)
    • Duration 7-10 days, 14 days if severe
    • Fluoroquinolones, tetracycline, or doxycycline can be used in mild to moderate cases, for a total of 14 days for oral therapy
    • Inherent resistance to beta-lactams
  • High rate of relapse

Immunocompromised Patients

  • Infections may appear different or less pronounced due to the damped host immune response
  • Differential diagnoss should include
    • Infectious: bacterial, fungal, viral, and parasitic infections
    • Non-infectious: drug eruption, cutaneous infiltration of malignancy, chemotherapy reactions, radiation reactions, Sweet syndrome, erythema multiforme, leukocytoclastic vasculitis, and graft-vs-host disease
  • Biopsy or aspiration should be implemented early

Cancer Patients with Febrile Neutropenia

  • Early aspiration or biopsy for etiology
  • Risk stratify with MASCC score
  • Investigate with blood cultures, CXR +/- chest CT

Ecthyma gangrenosum

  • A cutaneous vasculitis caused by invasion of the vessel wall media and adventitia by bacteria
  • Presents as painless erythematous papules that progress to pain and necrosis within 24 hours
  • Usually lower extremity
  • Caused by Pseudomonas aeruginosa, but also other Gram-negatives, some Gram-positives, and fungi, even HSV

Management

  • Vancomycin plus antipseudomonal antibiotics
  • Duration for most SSTIs is 7 to 14 days
  • Surgical intervention for source control, if appropriate
  • G-CSF is not routinely recommended
  • Acyclovir if disseminated HSV or VZV is suspected

Persistent or recurrent

  • Consider yeasts and molds, so need to add empiric antifungals
    • Candida spp. should be treated with an echinocandin
      • C. parapsilosis should be treated with amphotericin
      • Fluconazole is acceptable if sensitive
      • Duration is two weeks
    • Aspergillus spp. should be treated with voriconazole or amphotericin, posaconazole, or echinocandin
      • Duration is 6 to 12 weeks
    • Mucor/Rhizopus should be treated with amphotericin or posaconazole +/- an echinocandin
    • Fusarium should be treated with high-dose voriconazole or posaconazole
  • Ensure resistant bacteria are covered as well, with MRSA coverage and other broad-spectrum
  • Add acyclovir if HSV or VZV is suspected; PCR from blood may be helpful
  • Blood cultures and skin biopsy, aspiration, or culture is recommended for diagnosis
  • Galactomannan is unhelpful in patients on antifungals

Cellular Immunodeficiency

  • Lymphoma, leukemia, HSCT or SOT recipients, steroid use, other immunosuppressive agents
  • Consult a dermatologist, consider biopsy
  • Empiric antibiotcs, antifungals, and/or antivirals in life-threatening situations

Nontuberculous Mycobacteria

  • Mostly occurs at site of innoculation but can have hematogenous dissemination
  • Most common in SOT is cutaneous and pleuropulmonary disease
  • Most common in HSCT is cather-related infections and bacteremias
  • Mycobacterium avium complex occurs in HIV disease
  • Non-HIV species include: M. fortuitum, M. chelonae, M. abscessus, M. ulcerans, M. kansasii, M. haemophilum, M. marinum, M. mucogenicum
  • Skin infections can include a poorly-resolving cellulitis, painless 1 to 2 cm nodules, necrotic ulcers, and subcutaneous abscesses
  • Treatment is with combination antibiotics for 6 to 12 weeks

Nocardia

  • Cutaneous Nocardia is usually metastatic from a primary pulmonary infection
  • Species include N. farcinica, N. brasiliensis, and others
  • Skin involvement is usually subcutaneous nodules, abscesses, and panniculitis, often cold and painless
  • Septra for 6 to 24 months, though combination therapy should be considered in severe infections
  • Debride necrotic nodules and large abscesses

Fungi

  • Most common causes of cutaneous infection include Aspergillus, Mucormycosis, Scedosporium, and Fusarium
  • Can present as papules, nodules, ulcers, and ecthyma gangrenosum
  • Skin biopsy is helpful in diagnosis
  • Voriconazole good for Aspergillus, Scedosporium, and Fusarium
  • Cryptococcal infections usually involve lungs, with hematogenous spreading
    • Papules, nodules, pustules, chronic draining necrotic ulcers, or cellulitis
    • Fluconazole for milder infections
  • Disseminated histoplasmosis is rare and is treated with amphotericin for 1 to 2 weeks followed by itraconazole for 6 to 12 months

Viruses

  • VZV is common, sometimes disseminated
    • Dermatomal pain often preceeds the lesions by 24- to 72 hours
    • Duration of disease usually 2 weeks, but may progress slower in immunodeficient patients
    • Treated with high-dose IV acyclovir
    • Suspect resistance if it develops while on prophylaxis
  • HSV also common
    • Orofacial and genital sites most common, but can autoinnoculate any area
    • Often preceded by local pain or tingling
    • Disseminated disease is rare and usually associated with HSV-2
    • Acyclovir, famciclovir, and valacyclovir are all options
    • Foscarnet needed in cases of resistance

Parasites

  • Strongyloides stercoralis, amebae (Acanthamoeba and Balamuthia), Trypanosoma cruzi, and Sarcoptes scabiei (Norwegian scabies)